$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
乐伐替尼晚期HCC患者的新选择
2025-10-19 11:44:20
Check Details
肝炎的程度对索拉菲尼的总生存期影响很大
2025-10-19 11:44:20
Check Details
复发性肝癌唯一的靶向药物--索拉菲尼
2025-10-19 11:44:20
Check Details
HCV肝癌患者服用索拉菲尼治疗可获得更多受益
2025-10-19 11:44:20
Check Details
乐伐替尼治疗肝癌有效率
2025-10-19 11:44:20
Check Details
仑伐替尼治疗肝癌有哪些优势?
2025-10-19 11:44:20
Check Details
多吉美-肝癌抗癌药
2025-10-19 11:44:20
Check Details
多吉美可延长晚期肝细胞癌总生存期
2025-10-19 11:44:20
Check Details
肝功能损害的患者可以服用索拉非尼吗?
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗肝癌疗效显著
2025-10-19 11:44:20
Check Details
瑞格非尼治疗HCC患者可获得更久的生存期
2025-10-19 11:44:20
Check Details
欧盟批准卡博替尼用于肝癌的二线治疗
2025-10-19 11:44:20
Check Details
1
2
...
2564
2565
2566
2567
2568
2569
2570
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
2
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
3
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
4
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
5
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
6
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
7
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
8
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
9
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
10
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
11
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
12
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained